KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Aurinia Pharmaceuticals (AUPH) over the last 5 years, with Q3 2025 value amounting to $12.2 million.

  • Aurinia Pharmaceuticals' Treasury Shares rose 25882.35% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.2 million, marking a year-over-year increase of 25882.35%. This contributed to the annual value of $8.0 million for FY2024, which is 229.28% up from last year.
  • Aurinia Pharmaceuticals' Treasury Shares amounted to $12.2 million in Q3 2025, which was up 25882.35% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Treasury Shares ranged from a high of $14.8 million in Q2 2021 and a low of $347000.0 during Q4 2021
  • For the 5-year period, Aurinia Pharmaceuticals' Treasury Shares averaged around $6.8 million, with its median value being $7.8 million (2023).
  • The largest annual percentage gain for Aurinia Pharmaceuticals' Treasury Shares in the last 5 years was 47060.52% (2022), contrasted with its biggest fall of 8678.49% (2022).
  • Aurinia Pharmaceuticals' Treasury Shares (Quarter) stood at $347000.0 in 2021, then soared by 470.61% to $2.0 million in 2022, then skyrocketed by 294.29% to $7.8 million in 2023, then rose by 2.29% to $8.0 million in 2024, then skyrocketed by 52.77% to $12.2 million in 2025.
  • Its Treasury Shares stands at $12.2 million for Q3 2025, versus $11.2 million for Q2 2025 and $5.8 million for Q1 2025.